MAPT and Alzheimer disease: Cerebrospinal fluid (CSF) β-amyloid 42 (Aβ42), total tau (tau) and tau phosphorylated at threonine 181 (p-tau) are considered to reflect AD pathophysiology and make it possible to measure AD pathology ‘in vivo’ [16].